ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Device For Glioblastoma Multiforme

April 29, 2011

HHS, NIH To Help Houston Rebuild Research Facilities.

July 13, 2001

Fox Chase Cancer Center plans $1 billion expansion that would double its size.

October 22, 2004

Cancer Clinical Trials Approved By NCI Last Month Are Listed

October 25, 2002

In Brief: GSA Sitting On Breast Cancer Tapes; Creech, Owens Names President-Elect Of AACR, ASCO

May 27, 1977

The View Forom The White House On Research Funding

August 16, 1991